Application 010402
- Type
- NDA
- Sponsor
- WYETH PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PREMARIN | ESTROGENS, CONJUGATED | INJECTABLE;INJECTION | 25MG/VIAL | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N010402-001 | PREMARIN | ESTROGENS, CONJUGATED | 25MG/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | N010402-001 | PREMARIN | 25MG/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | N010402-001 | PREMARIN | 25MG/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N010402-001 | PREMARIN | 25MG/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N010402-001 | PREMARIN | 25MG/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Premarin | CONJUGATED ESTROGENS | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 87e2da8d-432c-4ed5-67a1-dc26294b2295 | 2025-05-30 | Boxed warning, Warnings, Adverse reactions | 010402 NDA010402 0046-0749 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0046-0749 | Premarin | CONJUGATED ESTROGENS | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | NDA | Current |
| 0046-0749 | Premarin | CONJUGATED ESTROGENS | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | NDA | Current |
| 0046-0749 | Premarin | CONJUGATED ESTROGENS | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | NDA | Current |
| 0046-0749 | Premarin | CONJUGATED ESTROGENS | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | NDA | Current |
| 0046-0749 | Premarin | CONJUGATED ESTROGENS | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 77560 | SUPPL | 2024-02-20 |
| 77513 | SUPPL | 2024-02-16 |
| 50305 | SUPPL | 2017-11-06 |
| 50283 | SUPPL | 2017-11-03 |
| 10750 | SUPPL | 2012-04-17 |
| 11902 | SUPPL | 2012-04-13 |
| 23529 | ORIG | 2009-06-02 |
| 33020 | SUPPL | 2008-03-05 |
| 221 | SUPPL | 2008-03-04 |
| 11901 | SUPPL | 2006-08-04 |
| 33019 | SUPPL | 2006-07-27 |
| 220 | SUPPL | 2006-06-06 |
| 33018 | SUPPL | 2005-09-07 |
| 11900 | SUPPL | 2005-09-07 |
| 33017 | SUPPL | 2005-01-21 |
| 11899 | SUPPL | 2005-01-21 |
| 219 | SUPPL | 2004-04-29 |
| 10749 | SUPPL | 2004-04-23 |